Dyslipidaemia in early rheumatoid arthritis patients is common and not influenced by two years of effective DMARD therapy. The Opera study.

Publikation: Bidrag til tidsskrift › Konferenceabstrakt i tidsskrift › Forskning › fagfællebedømt